Meet the 10 projects selected to compete at the Tecnimede Open Innovation Competition 2026 Final Event.
Biodiffuse
A bio-based alternative to titanium dioxide for pharmaceutical coatings, designed to improve opacity while reducing the need for dyes and synthetic additives.
CELLIMMUNE
A platform that transforms human stromal cells into stable microparticles, enabling targeted and controlled immunomodulation in a ready-to-use format.
Exobiosphere
A platform for developing advanced human disease models in microgravity, enabling more physiologically relevant and high-throughput drug testing in space.
GILDED
A therapeutic platform for type 2 diabetes that delivers specific microRNAs to protect the pancreatic cells responsible for insulin production.
NanoPyl
An antibiotic-free nanotechnology designed to treat H. pylori infections by physically disrupting the bacteria, helping reduce antibiotic resistance while preserving the microbiome.
ohmPRO
A nanoparticle-based therapy with intrinsic anticancer activity, designed to enhance treatment efficacy while reducing the amount of chemotherapy required.
PEPILSKIN
A multifunctional hydrogel for chronic wounds that combines antimicrobial action with tissue regeneration to support faster healing in conditions such as diabetic foot ulcers.
SafeAlleleSCA
WINNER – JORGE RUAS AWARD 2026
An AI-powered platform accelerating drug discovery for brain diseases by predicting blood-brain barrier permeability and reducing failure rates in Central Nervous System drug development.
SilenSCAs
A CRISPR-based gene therapy approach designed to permanently inactivate the disease-causing gene responsible for Machado-Joseph disease.
VTμA Accelerate
A high-throughput tissue-on-chip platform that creates vascularised human microtissues for more predictive, scalable and physiologically relevant drug testing.
